» Articles » PMID: 33530038

An Assessment of Cerebral Venous Thrombosis Risk Factors and Associated Clinical Outcomes in Jazan Region, Saudi Arabia

Overview
Specialty Neurology
Date 2021 Feb 2
PMID 33530038
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To assess cerebral venous thrombosis risk factors, and associated clinical outcomes in Jazan region, Kingdom of Saudi Arabia.

Methods: This study is a retrospective review of the medical records of patients diagnosed with cerebral venous thrombosis and admitted to King Fahad Central Hospital in Jazan between 2010 and 2019. Data concerning socio-demographics, clinical features, risk factors, laboratory, and imaging investigations were retrieved. Furthermore, data about cases management, and outcomes, including death, were collected and analysed.

Results: A total of 51 medical records were identified. The majority of the patients were females (68.6%), and the mean age of the patients was 33.3 years, of which three patients were under 18 years old. The most frequently recorded symptom was headache (76.5%), followed by seizure (45.1%). The most commonly recorded risk factor was protein S deficiency (57%), followed by anaemia (51%). Venous infarction and haemorrhage were the most common acute complications (13.7%). The majority of the patients had a favourable prognosis where only 27.5% recovered with disability and only one patient died due to the disease.

Conclusion: Clinical presentation of cerebral venous thrombosis in Jazan region is similar to other local and international studies. However, anaemia was recorded as a main risk factor for the disease, which might require further investigation to assess the possible association between prevalence of anaemia in Jazan region and the incidence of cerebral venous thrombosis.

Citing Articles

Comparison of natural anticoagulant deficiency in cerebral venous thrombosis with deep venous thrombosis.

Tran S, Vu M, Nguyen T, Nguyen T, Pham P, Hoang T Med Int (Lond). 2025; 5(2):19.

PMID: 39990725 PMC: 11843084. DOI: 10.3892/mi.2025.218.


Knowledge and Perceptions of Cerebral Venous Thrombosis Among the Adult Population: A Nationwide Cross-Sectional Study in Saudi Arabia.

Alhadi W, Alshehry E, Hamood N, Albishri L, Al Hunaif G, Al Murayyi R Int J Gen Med. 2024; 17:4189-4204.

PMID: 39308970 PMC: 11416108. DOI: 10.2147/IJGM.S470463.


Outcomes and complications of patients with cerebral venous thrombosis: a retrospective study.

Almegren M, Alharbi S, Alshuaibi T, Almansour M, Alharbi K, Al Rawahi B Neurosciences (Riyadh). 2024; 29(1):32-36.

PMID: 38195128 PMC: 10827010. DOI: 10.17712/nsj.2024.1.20230050.

References
1.
Nasr D, Brinjikji W, Cloft H, Saposnik G, Rabinstein A . Mortality in cerebral venous thrombosis: results from the national inpatient sample database. Cerebrovasc Dis. 2013; 35(1):40-4. DOI: 10.1159/000343653. View

2.
Kajtazi N, Zimmerman V, Arulneyam J, Al-Shami S, Al-Senani F . Cerebral venous thrombosis in Saudi Arabia. Clinical variables, response to treatment, and outcome. Neurosciences (Riyadh). 2010; 14(4):349-54. View

3.
Algahtani H, Abdu A, Shami A, Hassan A, Madkour M, Al-Ghamdi S . Cerebral venous sinus thrombosis in Saudi Arabia. Neurosciences (Riyadh). 2011; 16(4):329-34. View

4.
Janghorbani M, Zare M, Saadatnia M, Mousavi S, Mojarrad M, Asgari E . Cerebral vein and dural sinus thrombosis in adults in Isfahan, Iran: frequency and seasonal variation. Acta Neurol Scand. 2008; 117(2):117-21. DOI: 10.1111/j.1600-0404.2007.00915.x. View

5.
Shahid R, Zafar A, Nazish S, Alsulaiman A, Alabdali M, Aljaafari D . Etiologic and Clinical Features of Cerebral Venous Sinus Thrombosis in Saudi Arabia. J Neurosci Rural Pract. 2019; 10(2):278-282. PMC: 6454937. DOI: 10.4103/jnrp.jnrp_305_18. View